Attachment
Fauci Intelligence Community Release, p.73 · fauci_intel:exh:00024
Page text: p.73 · original PDF
- Date
- — (unknown precision)
- Type
- attachment · document
UNCLASSIFIED
UNCLASSIFIED
Furthermore, the EcoHealth proposal states that a "vaccine approach lacks
sufficient epitope coverage to protect against quasispecies of
coronavirus."x Consequently, they were trying to make vaccines work by
"targeted immune boosting via vaccine inoculators using chimeric
polyvalent recombinant spike proteins."xi The nature of using a spike
protein vaccine with one epitope against a spike protein vaccine with a
quasispecies may explain the unusual (and potentially detrimental)
antibody response amongst the vaccinated to the new COVID variants.xii
Fundamentally, the knowledge the proposal provides signals that the risk
of Antibody Dependent Enhancement (ADE) from vaccination should be
evaluated with high priority, on top of the reality that single-epitope
vaccines will have little effect against SARSr-CoV-WIV, as indicated in
the proposal.
The potential for SARSr-CoV-WIV to deattentuate requires immediate
attention. Live vaccines have been found to deattentuate in the past.
If this is the case with SARSr-CoV-WIV, then the mass vaccination
campaign actually performs an accelerated gain-of-function for it. Since
it is designed for bats off of a human-susceptible SARS-CoV, vaccinating
humans against it actually gains its function back towards a more
deattenuated human-susceptible form. Improving the SARSr-CoV-WIV spike
protein to gain robustness against monoclonal vaccines is one of the
steps of the DEFUSE program. The mechanism to improve the SARSr-CoV-WIV
spike protein (other than direct engineering) is to challenge it against
animals that have spike protein-only antibodies. The attenuated virus
will either die or adapt its form to neutralize the spike protein-only
antibodies. The intent was to perform this task against humanized mice
and then "batified" mice. Instead, it was done with the world's
population.
SARSr-CoV-WIV is not meant to kill the bats, but to immunize them. This
nature may explain its general harmlessness to most people, and its
harmfulness to the old and comorbid, who are in general more susceptible
to vaccine reactions. The asymptomatic nature is also explained by the
bat vaccine-intention of its creators (a good vaccine does not generate
symptoms). Such effects would be expected of an immature vaccine, or a
vaccine being reverse engineered from a more virulent form into an
attenuated form. The spike protein effect on ACE2 receptors exacerbates
the harmfulness in accordance with age and comorbidity. The nature of
SARSr-CoV-WIV's deattentuation will also indicate future virulence,
though knowing its nature at last neutralizes the threat as effective
treatments can be applied with confidence.
3. DRASTIC and other scientists will clean up my description of SARSrCoV-WIV's nature and progression within the DEFUSE program. This
information is sufficient for an investigative report and more than
enough to correct the existing pandemic strategy. Previously, the nation
did not know itself, nor the adversary in the pandemic conflict. Now it
knows both. The problem can be framed appropriately and specifically
against a confirmed hypothesis. Limiting disease transmission can be
dropped as the implied strategic end, as it is not the actual problem,
For SHSGAC Use Only - SHSGAC_COVID_119th 011835